Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
5.08
+0.01 (0.20%)
At close: Feb 27, 2026
Market Cap5.36B +46.4%
Revenue (ttm)771.02M -10.0%
Net Income-107.30M
EPS-0.10
Shares Out1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,821,478
Average Volume24,920,567
Open5.07
Previous Close5.07
Day's Range5.04 - 5.12
52-Week Range2.77 - 6.14
Beta0.31
RSI48.84
Earnings DateMar 21, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 1,019
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2024, SHE:300006's revenue was 795.60 million, a decrease of -11.17% compared to the previous year's 895.59 million. Losses were -87.80 million, 883.5% more than in 2023.

Financial Statements